Citadel Advisors’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$59.2M Buy
501,011
+199,806
+66% +$24.7M 0.01% 1197
2025
Q4
$37.9M Sell
301,205
-69,022
-19% -$9M 0.01% 1676
2025
Q3
$54.2M Sell
370,227
-340,589
-48% -$51.5M 0.01% 1301
2025
Q2
$111M Buy
710,816
+627,630
+754% +$99.5M 0.02% 703
2025
Q1
$13.7M Sell
83,186
-1,007,313
-92% -$168M ﹤0.01% 2473
2024
Q4
$178M Buy
+1,090,499
New +$195M 0.03% 450
2024
Q3
Sell
-261,279
Closed -$48.1M 15404
2024
Q2
$45.3M Sell
261,279
-1,518,279
-85% -$253M 0.01% 1224
2024
Q1
$301M Buy
1,779,558
+1,717,026
+2,746% +$322M 0.06% 238
2023
Q4
$12.3M Buy
62,532
+36,801
+143% +$6.51M ﹤0.01% 2584
2023
Q3
$4.48M Buy
25,731
+24,559
+2,095% +$4.46M ﹤0.01% 3839
2023
Q2
$202K Sell
1,172
-359,138
-100% -$62.1M ﹤0.01% 9873
2023
Q1
$60M Sell
360,310
-492,325
-58% -$80.7M 0.01% 935
2022
Q4
$125M Buy
852,635
+544,348
+177% +$80.6M 0.03% 534
2022
Q3
$45.7M Sell
308,287
-338,971
-52% -$56.7M 0.01% 1143
2022
Q2
$111M Buy
647,258
+164,328
+34% +$28.4M 0.03% 524
2022
Q1
$91.1M Buy
482,930
+144,020
+42% +$28.5M 0.02% 712
2021
Q4
$82.7M Buy
338,910
+19,908
+6% +$4.36M 0.02% 792
2021
Q3
$61.9M Sell
319,002
-127,441
-29% -$25.7M 0.01% 964
2021
Q2
$83.2M Sell
446,443
-434,039
-49% -$75.4M 0.02% 779
2021
Q1
$139M Buy
880,482
+569,015
+183% +$90.2M 0.03% 440
2020
Q4
$51.5M Sell
311,467
-505,742
-62% -$82.2M 0.01% 929
2020
Q3
$135M Buy
817,209
+235,112
+40% +$36.1M 0.04% 318
2020
Q2
$79.8M Sell
582,097
-73,195
-11% -$9.56M 0.03% 517
2020
Q1
$77.1M Sell
655,292
-34,689
-5% -$4.57M 0.03% 441
2019
Q4
$91.3M Sell
689,981
-660,369
-49% -$82.1M 0.04% 438
2019
Q3
$168M Buy
1,350,350
+549,455
+69% +$66.3M 0.08% 203
2019
Q2
$90.9M Sell
800,895
-284,198
-26% -$29.8M 0.04% 431
2019
Q1
$109M Buy
1,085,093
+601,156
+124% +$54.6M 0.05% 330
2018
Q4
$41.4M Sell
483,937
-56,028
-10% -$5.05M 0.02% 721
2018
Q3
$49.4M Buy
539,965
+220,861
+69% +$19.6M 0.02% 768
2018
Q2
$27.2M Buy
319,104
+94,512
+42% +$7.98M 0.01% 1075
2018
Q1
$18.8M Buy
224,592
+161,367
+255% +$12.7M 0.01% 1175
2017
Q4
$4.55M Sell
63,225
-43,287
-41% -$2.97M ﹤0.01% 2579
2017
Q3
$6.79M Sell
106,512
-639,764
-86% -$40.1M 0.01% 1966
2017
Q2
$46.6M Buy
746,276
+342,135
+85% +$20.2M 0.04% 536
2017
Q1
$21.6M Buy
404,141
+355,204
+726% +$19.2M 0.02% 901
2016
Q4
$2.62M Buy
+48,937
New +$2.49M ﹤0.01% 2651
2016
Q1
Sell
-3,033,625
Closed -$129M 8127
2015
Q4
$145M Buy
3,033,625
+1,575,265
+108% +$71.2M 0.16% 113
2015
Q3
$60.1M Buy
1,458,360
+545,424
+60% +$25.3M 0.06% 354
2015
Q2
$44M Buy
912,936
+252,164
+38% +$12M 0.04% 563
2015
Q1
$30.6M Sell
660,772
-225,108
-25% -$10.1M 0.03% 741
2014
Q4
$38.1M Buy
885,880
+842,824
+1,958% +$34.2M 0.04% 598
2014
Q3
$1.59M Sell
43,056
-8,322
-16% -$285K ﹤0.01% 3123
2014
Q2
$1.66M Sell
51,378
-102,433
-67% -$3.14M ﹤0.01% 2930
2014
Q1
$4.45M Sell
153,811
-875,891
-85% -$26.8M 0.01% 1890
2013
Q4
$33.7M Sell
1,029,702
-26,422
-3% -$843K 0.04% 534
2013
Q3
$32.9M Buy
1,056,124
+980,251
+1,292% +$30M 0.05% 489
2013
Q2
$2.34M Buy
+75,873
New +$2.46M ﹤0.01% 2344

Other funds holding ZTS

Citadel Advisors's ZTS Position: Q1 2026 in Review

Citadel Advisors increased its Zoetis (ZTS) stake by 66% in Q1 2026, buying an estimated $24.7M and bringing the position to 501,011 shares worth $59.2M. The position accounts for 0.01% of the portfolio, ranked #1197.

Citadel Advisors first reported a position in ZTS in Q2 2013 and has held it in 48 quarters since. The position peaked at $301M in Q1 2024. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Citadel Advisors held 501,011 shares of Zoetis worth $59.2M as of Q1 2026.
  • Citadel Advisors bought 199,806 Zoetis shares in Q1 2026, an estimated $24.7M.
  • Zoetis made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1197 holding.
  • Citadel Advisors first reported a position in Zoetis in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Zoetis position peaked at $301M in Q1 2024.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.